BMS launches #Daklinza (daclatasvir) in the UK for HCV. It will be very interesting to monitor early patterns of use. http://www.thepharmaletter.com/article/bristol-myers-squibb-launches-daklinza-in-the-uk-for-chronic-hepatitis-c

#BMS news don't change status of #Sunvepra/#Daklinza combo approved in Japan for #HCV GT1b and #daclatasvir in EU as combo with other drugs

# FDA approves #daclatasvir as new treatment for chronic #HCV genotype 3 #daklinza

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm455888.htm#.VbKA3Y5fnSU.twitter

#daklinza + #sovaldi for 12 wks is IFN/RBV free for #HCV GT3 non cirrhotics. Limitations of Use statement for SVR reduction in cirrhotics

#HCV combo of #sovaldi and #daklinza effective in Real World experience for #HIV co infected http://www.medpagetoday.com/MeetingCoverage/IAS/52751

#daklinza #sovaldi combo +/- ribavirin in #AASLD/#IDSA guidelines for #HCV GT1-3 rx naive and experienced patients based on ALLY studies

@regulusRx initiated #HCV phase 2 studies for RG-101 in combination with #harvoni #daklinza and #olysio with interim data by end of year

FDA expands #daklinza label with #sovaldi to #HCV GT1-3 incl. post-transplant, #HIV co-infection & cirrhosis #$BMY http://www.streetinsider.com/dr/news.php?id=11284730

New #daklinza/hashtag/daklinza" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link">#daklinza label explicitly includes cirrhosis child B & C and recommends #daklinza #sofosbuvir and #ribavirin for 12 wks for #HCV GT1-3

New #HCV black box warning for #HBV reactivation affects #harvoni #epclusa #viekira #zepatier #daklinza #sovaldi #olysio #technivie